Valneva falls as UK revokes marketing authorization for chikungunya vaccine
FROM THE WIRE · SEEKINGALPHA.COM
Valneva stock drops after UK MHRA revokes Ixchiq chikungunya vaccine authorization over safety concerns. Read more here.
Read at the source ↗MARKET IMPACTHIGH✦ News Impact agent estimateTone: expected bearishRevocation of key product authorization over safety concerns is material event for stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01UK MHRA revokes marketing authorization for Valneva's Ixchiq chikungunya vaccine.
- 02Revocation is due to safety concerns.
- 03Event represents significant blow to Valneva's product portfolio.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets